Citation: G. Matfin et al., SERUM ALPHA-IMMUNOREACTIVE INHIBIN (1-32) LEVELS IN PATIENTS WITH END-STAGE RENAL-DISEASE (ESRD) - RESPONSE TO GNRH TESTING, Journal of the American Society of Nephrology, 8, 1997, pp. 1871-1871
Citation: W. Jenq et al., HYPOXIC EFFECTS ON THE EXPRESSION OF MINERALOCORTICOID AND GLUCOCORTICOID RECEPTORS IN HUMAN RENAL-CORTEX EPITHELIAL-CELLS, Biochemical and biophysical research communications, 218(2), 1996, pp. 444-448
Authors:
ROSEN R
PEREZ E
WAHE M
RAMIREZ G
BALLESTER O
ELFENBEIN G
Citation: R. Rosen et al., MANAGEMENT OF DIALYSIS DEPENDENT MULTIPLE-MYELOMA PATIENTS DURING AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Journal of the American Society of Nephrology, 6(3), 1995, pp. 401-401
Authors:
ANTONIPILLAI I
WAHE M
YAMAMOTO J
HORTON R
Citation: I. Antonipillai et al., ACTIVIN AND INHIBIN HAVE OPPOSITE EFFECTS ON STEROID 5-ALPHA-REDUCTASE ACTIVITY IN GENITAL SKIN FIBROBLASTS, Molecular and cellular endocrinology, 107(1), 1995, pp. 99-104
Citation: M. Wahe et al., EFFECTS OF TRANSFORMING GROWTH-FACTOR-BETA AND EPIDERMAL GROWTH-FACTOR ON STEROID 5-ALPHA-REDUCTASE ACTIVITY IN GENITAL SKIN FIBROBLASTS, Molecular and cellular endocrinology, 98(1), 1993, pp. 55-59